ARGENICA THERAPEUTICS LIMITED

AGN

equity

AUD $0.45

0.005 (1.12%)

Updated: 20 Jan, 5:10 am UTC

Description

Argenica Therapeutics Limited is a biopharmaceutical company focused on the development of first-in-class therapies for serious cardiovascular diseases. Its main objective is to develop drug candidates that target the renin-angiotensin-aldosterone system and improve clinical outcomes for patients with cardiovascular diseases. The company has several ongoing projects, including the development of two novel drug candidates in preclinical studies to treat cardiovascular diseases.

Activity
Last price		$0.45
Change		0.005 (1.12%)
Bid/Ask		$0.45 - $0.48
Volume		20,737.00
Volume traded/total %		0.024%
Volume avg (4w)		73,572.00
Open		$0.47
Day range		$0.45 - $0.47
Previous Close		$0.45
Last Trade		20 Jan, 5:10 am UTC

Size
Market Cap		$38.68M
Market Rank		1537
Industry Rank		51

Fundamentals
Shares Issued		86.92M
Earnings Per Share (EPS)		$-0.055
Dividends Per Share (DPS)		-
P/E Ratio		-

Similar to